Chong Kun Dang Pharmaceutical (185750) — Long-term Investment Intensity
Chong Kun Dang Pharmaceutical (185750) has a Long-term Investment Intensity of 3.1% as of December 2019. Long-term investments of ₩25.09 Billion represent 3.1% of total assets of ₩801.35 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Chong Kun Dang Pharmaceutical (185750) net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Chong Kun Dang Pharmaceutical Long-term Investment Intensity (2016–2019)
This chart shows how Chong Kun Dang Pharmaceutical's Long-term Investment Intensity has evolved across 4 annual periods from 2016 to 2019. As of December 2019, the intensity stands at 3.1%, reflecting long-term investments of ₩25.09 Billion against total assets of ₩801.35 Billion KRW. Also explore Chong Kun Dang Pharmaceutical balance sheet assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Chong Kun Dang Pharmaceutical (2016–2019)
The table below presents the year-by-year Long-term Investment Intensity for Chong Kun Dang Pharmaceutical from 2016 to 2019, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Chong Kun Dang Pharmaceutical market cap and net worth.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 3.1% | ₩25.09 Billion | ₩801.35 Billion | ▼ -0.4 pp |
| 2018 | 3.5% | ₩24.83 Billion | ₩711.49 Billion | ▲ +0.9 pp |
| 2017 | 2.6% | ₩17.84 Billion | ₩677.21 Billion | ▼ -0.3 pp |
| 2016 | 2.9% | ₩18.51 Billion | ₩641.70 Billion | — |